MedOncMD

To provide the information your oncologist is not telling you or doesn't have the time to!

  • Home
  • Blog
    • The essentials
    • Art of Oncology
    • Prevention and Healthy Lifestyle
    • Research Advances
    • Navigation Corner
    • Video Library
  • Meet and Greet
    • About Dr Thomas
    • About Dr Landau
  • Ask MedOncMD?
  • 🧠 How I Create My Blog Posts

Varied Cancer Perspectives

Explore a comprehensive range of insights and information within our ‘Varied Cancer Perspectives’ category. From melanoma to breast cancer, colorectal cancer to sarcoma, and beyond, this diverse collection delves into the multifaceted world of oncology. Gain a nuanced understanding of different cancer types, treatments, and the latest advancements in research. Whether you’re seeking knowledge on pediatric oncology, uveal melanoma, or desmoid tumors, our curated content provides a holistic view, offering valuable perspectives to empower and inform those navigating the complexities of cancer care. Join us on a journey through varied perspectives, ensuring a well-rounded understanding of the ever-evolving landscape of cancer.

Neuroendocrine tumors (NETs) are a rare type of cancer that originates in the neuroendocrine cells, which are found throughout the body. While these tumors can occur in various organs such as the pancreas, lungs, intestines, and appendix, they can also develop in other less common sites. 

Understanding Neuroendocrine Tumors (NETs): A Comprehensive Overview

Neuroendocrine tumors (NETs) are a rare type of cancer that originates in the neuroendocrine cells, which are found throughout the body. While these tumors can occur in various organs such as the pancreas, lungs, intestines, and appendix, they can also develop in other less common sites.  In this article, we will dive into the basics …

Read On »

Cellular Therapy Trial: A Step Forward in Precision Oncology Targeting MAGE-A1, HPV16, and PRAME

I am very excited to announce the opening of a new Cellular Therapy by Tscan Therapeutics using TCR protocol at the Orlando Health Cancer Institute (OHCI) targeting Melanoma, Head/Neck Cancer, NSCLC, Ovarian, and HPV positive Anal-Cervical SCC. Information for this new open clinical trial was provided from a public source. Please reach out to Karin …

Read On »

Echoes of Victory: The Significance of Ringing the Bell into Cancer Remission

Embarking on the tumultuous journey that is stage IV melanoma, both patients and healthcare providers often find themselves in an intricate dance of vulnerability, resilience, and human connection. This is the poignant tale of a young man’s persistent battle against melanoma, his remarkable perseverance through a myriad of treatments, and the eventual moment of triumph …

Read On »

The Promising Intersection of Fecal Microbiota Transplantation and Cancer Immunotherapy: An Emerging Frontier for Refractory Melanoma Treatment

This post is based on the interesting results published by Routy et al. Nature July 2023. I am hoping that we will soon open a protocol using FMT in cancer patients and I will announce once we’re site activated at the Orlando Health Cancer Institute. The revolutionary world of cancer treatment is once again on …

Read On »

Breast cancer screening

Breast Cancer Screening Guidelines: What Women Need to Know

Breast cancer is a significant health concern affecting women worldwide. With October being Breast Cancer Awareness Month, it is crucial for women to understand the importance of regular breast cancer screenings. Regular screenings, including mammograms and self-exams, play a vital role in detecting breast cancer early, improving treatment outcomes, and saving lives. In this article, …

Read On »

Breast caner and mental health

Breast Cancer and Mental Health: Navigating the Emotional Journey

A breast cancer diagnosis is a life-altering event that extends its impact far beyond the physical realm. It sends ripples through the emotional and psychological landscape, affecting not only the patient but also their families. In recognition of Breast Cancer Awareness Month, let’s delve into the emotional journey that often accompanies a breast cancer diagnosis …

Read On »

Breast cancer awarness month

Understanding Breast Cancer Risk Factors: What You Need to Know

Breast cancer, a formidable adversary, affects millions of lives worldwide each year. In our quest to combat this disease, knowledge is the most potent weapon we have. Breast Cancer Awareness Month is the ideal time to explore the intricacies of breast cancer risk factors, from the genetic underpinnings to lifestyle choices that can influence your …

Read On »

Uveal melanoma, a rare and aggressive form of eye cancer, has just witnessed a groundbreaking development in its treatment landscape. The Food and Drug Administration (FDA) recently granted approval to the HEPZATO KIT, an innovative liver-directed therapy that offers new hope to adult patients with uveal melanoma and unresectable hepatic metastases.

A Breakthrough in Uveal Melanoma Treatment: HEPZATO KIT

Uveal melanoma, a rare and aggressive form of eye cancer, has just witnessed a groundbreaking development in its treatment landscape. The Food and Drug Administration (FDA) recently granted approval to the HEPZATO KIT, an innovative liver-directed therapy that offers new hope to adult patients with uveal melanoma and unresectable hepatic metastases.

CLN-617-001: A Promising New Study Combines Intratumoral Therapy with Immune Therapy 

Intratumoral therapies is another class of immunotherapeutics that I often consider especially for folks with limited skin or nodal disease or perhaps deeper oligometastatic disease. I have cutaneous malignancies patients with Melanoma, Cutaneous SCC, Merkel cell and Kaposi sarcomas that have responded to local intratumoral therapies. We’ve seen viral agents like FDA approved TVEC, RP1, …

Read On »

Dacarbazine, referred to as DTIC, is a chemotherapy administered intravenously every 3 weeks. Unesbulin is a novel, oral drug, administered twice weekly and is currently being researched in the treatment of advanced solid tumors. In this case, it is being studied in conjunction with DTIC for treatment of metastatic or unresectable, relapsed or refractory Leiomyosarcoma. Participants can be randomized to receive either DTIC with Unesbulin or DTIC with placebo.  

About Leiomyosarcoma – A look at new advances by Chloe Caldwell

In terms of cancer diagnoses, the more common ones we hear of are cancers such as Leukemia, Lymphoma, melanoma, and breast cancer. But what about Leiomyosarcoma?

Leiomyosarcoma is a rare and aggressive form of cancer that develops in the smooth muscles of the body (i.e. intestines, stomach, uterus, blood vessels).

  • Previous
  • Page 1
  • …
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Next

Recent Posts

  • SITC 2026 Phoenix: Notes From the Front Row of Immunotherapies
  • ESMO 2026 – NADINA Neoadjuvant Immunotherapy: We Kept the Baby But Are WE Throwing Out the Nursery?
  • A Cancer Vaccine That Works
  • ESMO 2026, Day 1: What’s New in Melanoma
  • A Year of Firsts, and Day 1 at ESMO in Madrid

Categories

  • Art of Oncology (101)
  • Current News (19)
  • Immunotherapy News (13)
  • Navigation Corner (6)
  • Prevention and Healthy Lifestyle (18)
  • Reflections (3)
  • Research Advances (126)
    • Clinical Trials (54)
    • Immunotherapy (36)
    • New Treatments and Therapies (44)
  • The essentials (41)
    • Radiology (4)
  • Travel Health (1)
  • Uncategorized (10)
  • Varied Cancer Perspectives (130)
    • Biliary tract cancer (3)
    • Bladder Cancer (3)
    • Breast Cancer (10)
    • Cervical Cancer (2)
    • CNS Cancers (1)
    • Colorectal cancer (15)
    • Esophageal Cancer (2)
    • Gastric cancer (6)
    • Hepatic Tumors (1)
    • Leiomyosarcoma (2)
    • Leukemia (3)
    • Lung Cancer (11)
    • Lymphoma (3)
    • Melanoma (38)
    • Multiple Myeloma (3)
    • Neuroendocrine cancer (2)
    • Ovarian Cancer (3)
    • Pancreatic Cancer (5)
    • Prostate Cancer (5)
    • Sarcoma (2)
    • Sickle Cell Disease (4)
    • Skin Cancer (9)
    • Thyroid cancer (1)
    • Urothelial Cancer (1)
  • Video (2)
  • Weekly Newsletter (6)

Get in touch!

  • Facebook
  • Instagram
  • TikTok
  • LinkedIn


Meet the authors

Dr. Sajeve Thomas
Dr Daniel Landau


Subscribe


  • Home
  • Blog
    • The essentials
    • Art of Oncology
    • Prevention and Healthy Lifestyle
    • Research Advances
    • Navigation Corner
    • Video Library
  • Meet and Greet
    • About Dr Thomas
    • About Dr Landau
  • Ask MedOncMD?
  • 🧠 How I Create My Blog Posts
© 2026 MedOncMD. Minimal Theme by SPYR
✕
  • Home
  • Blog
    • The essentials
    • Art of Oncology
    • Prevention and Healthy Lifestyle
    • Research Advances
    • Navigation Corner
    • Video Library
  • Meet and Greet
    • About Dr Thomas
    • About Dr Landau
  • Ask MedOncMD?
  • 🧠 How I Create My Blog Posts